Heart failure therapy at a crossroad: are there limits to the neurohormonal model? (Q35125701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Heart failure therapy at a crossroad: are there limits to the neurohormonal model? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Patricia A Uber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gary S Francis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1606-1610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

CHF: circulatory homeostasis gone awry

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Pathophysiology of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Neurohumoral blockade in CHF management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Ranolazine: a potential new treatment for chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Emergence of Laplace therapeutics: declaring an end to end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

New surgical treatments for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Current status and future expectations for multisite pacing in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Influence of progressive renal dysfunction in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900245-6

7 January 2021

10.1016/S0735-1097(03)00245-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742304%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference